Declining Trust in Healthcare Institutions
Before the pandemic, Americans generally had a solid trust in healthcare systems, regardless of their political views. However, this trust has significantly declined over time due to the challenges posed by COVID-19.
In April 2020, during the height of the pandemic, an impressive 71.5% of Americans expressed considerable trust in doctors and hospitals. Fast forward to January 2024, and that figure has dropped sharply to a mere 40.1%.
Today, this trust decline underscores deeper worries. Many individuals feel that healthcare decisions now prioritize corporate profits and financial incentives over patient welfare.
To rebuild faith in the healthcare system, a fundamental principle should guide us: prioritizing patients over profits. This mission is what drives The Wellness Company.
Dr. Peter McCullough and his team have opened doors to new avenues in cancer research through their work with Ivermectin and Mebendazole.
84.4% of cancer patients reported clinical benefits
A recent observational study has found that an impressive 84.4% of patients experienced clinical benefits while using these off-label drugs in cancer treatment. This suggests that widely available and affordable drugs could lead to significant advancements in cancer care.
In a groundbreaking report, 197 cancer patients were treated using a combination of Ivermectin (25 mg) and Mebendazole (250 mg) as outlined by the Chief Medical Committee of The Wellness Company and the McCullough Foundation.
Among the 122 patients who completed six months of follow-up:
- 84.4% noted clinical benefits (No evidence of disease, tumor shrinkage, or stable disease)
- 48.4% reported the most significant positive outcomes (Tumor reduction or absence of disease)
- 86.9% completed their initial prescription (Most side effects reported were mild)
These two FDA-approved and Nobel Prize-winning compounds function through a dual mechanism. Ivermectin disrupts tumor growth pathways and promotes cancer cell death, while Mebendazole inhibits glucose uptake, effectively starving abnormal cells. Together in a single capsule, they offer a manageable protocol for patients.
With one in three individuals facing a cancer diagnosis in their lifetime, standard treatments such as chemotherapy and radiotherapy often come with severe side effects, high expenses, and varying long-term effectiveness.
In light of these obstacles, researchers at The Wellness Company set out to investigate alternative methods. Both Ivermectin and Mebendazole have shown strong anticancer properties in preliminary studies, and their safety is well established. Yet, rigorous clinical data on their combined use in cancer therapy is still lacking, making this research crucial for understanding their potential in oncology.
Dr. McCullough states, “This study highlights a promising new avenue worth exploring further for using Ivermectin and Mebendazole in treating various cancers. Serious scientific inquiry into this drug class and its impact on cancer therapy is urgently necessary.”
How to Acquire Ivermectin and Mebendazole
The Wellness Company uniquely formulates the U.S. combination of Ivermectin and Mebendazole in high-dose tablets.
Ivermectin – Supported by scientific evidence and recognized with a Nobel Prize, this drug offers targeted treatment for parasitic infections, ensuring effective care for your family.
Mebendazole – Trusted by healthcare professionals, Mebendazole effectively targets and eliminates intestinal parasites, promoting your family’s health with proven efficacy and safety.
You can purchase a 45-day or 90-day supply of Ivermectin + Mebendazole, known as a potent parasite treatment. After checkout, simply fill out a brief medical intake form to finalize your prescription request. Available for U.S. residents only.
What People Are Saying
I was diagnosed with stage 4 metastatic breast cancer and was told it was terminal. A recent PET scan showed no viable cancer in my body. Honestly, Ivermectin and Mebendazole were life-changers. – Judith M.
My daughter faced uterine cancer and lung nodules. After starting Ivermectin and Mebendazole two weeks ago, her PET scan revealed that the nodules were significantly reduced. Thankful for the hope and healing! – Helen
